MAXIMIZING ONCOLOGY STUDY WITH INTEGRATED KRAS ASSAY SERVICES AND RAS ASSAYS

from the rapidly evolving subject of oncology research, correct and efficient mutation screening is vital for establishing targeted therapies. The KRAS solutions Platform performs a pivotal job In this particular landscape by presenting comprehensive methods for KRAS mutation profiling and analysis. KRAS mutations, found in roughly ninety five% of